Early Feasibility Study of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System (TIARA-I)
A study for patients with Mitral valve disease using a new device called Neovasc Tiara
Sponsor: Neovasc Inc.
Enrolling: Male and Female Patients
IRB Number: AAAO5703
U.S. Govt. ID: NCT02276547
Contact: Martin Leon: 212-342-3617 / ml2398@columbia.edu
Additional Study Information: The purpose of this study is to find out if the mitral valve can be safely replaced using a procedure that issimpler than the open-heart procedure being used today and may be safer for patients who are at ahigher risk from conventional open-heart surgery. The device being studied would be implanted without the need for an open-heart procedure and without the need for a heart and lung machine. This is thefirst research study for this device that will be carried out in a small number of subjects. This study is being done to learn initial information about the basic safety and function of this device.
This study is closed
Martin Leon, MD
Do You Qualify?
Are you at high surgical risk for open mitral valve surgery? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Martin Leon